Position in A
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$376,041
+$47,779 QoQ
Shares Held
2,831
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#694
of 1,119 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $6,917,655 across 7 Diagnostics & Research names. A ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
43,092 | $2,958,265 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
2,651 | $1,395,592 | |
| 3 | OPK |
Opko Health, Inc.
|
536,202 | $804,303 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
1,410 | $706,917 | |
| 5 | A |
Agilent Technologies, Inc.
This page
|
2,831 | $376,041 | |
| 6 | DHR |
Danaher Corp /De/
|
1,873 | $356,769 | |
| 7 | NTRA |
Natera, Inc.
|
1,178 | $319,768 |
All Filings in A
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $376,041 | 2,831 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $328,262 | 2,880 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $385,078 | 2,830 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $233,597 | 1,820 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $202,859 | 1,719 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $201,088 | 1,719 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $244,364 | 1,819 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $270,085 | 1,819 | Shares | Sole | 2024-11-05 | |
| 2021-12-31 | $254,162 | 1,592 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $247,794 | 1,573 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||